Human Insulin
Human Insulin is listed in the FDA National Drug Code directory with 8 NDC codes, marketed under brand names including Novolin 70/30, Novolin R, Novolin N. Available dosage forms: injection, suspension, injection, solution.
Drug Details
- Generic Name
- Human Insulin
- Brand Names
- Novolin 70/30, Novolin R, Novolin N
- Application Number
- BLA019991
- Sponsor
- Novo Nordisk
- NDC Codes
- 8
- Dosage Forms
- INJECTION, SUSPENSION, INJECTION, SOLUTION
- Routes
- SUBCUTANEOUS
- Active Ingredients
- INSULIN HUMAN
Indications and Usage
1 INDICATIONS AND USAGE NOVOLIN R is indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus. NOVOLIN R is a short-acting human insulin indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus ( 1 ).